Iron Sorbitol
Overview
Iron Sorbitol is a complex of ferric, sorbitol and citric acid, stabilised with dextrin and sorbitol. It should be used only in the treatment of proven iron-deficiency anaemia, where oral therapy is ineffective or inappropriate. Iron Sorbitol is given parenterally. Severe anaphylactoid reactions may occur after parenteral administration.
Categories
- 10 Drugs affecting the blood
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Oral absorption of Iron Sorbitol is found to be 33% ±33. Plasma half life is 3 hr.
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Iron Sorbitol's dosage details are as follows:
Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
2 ml | 2 (2) | As recommended. | IM | This two mL iron sorbitol contains the recommended single daily dose (100 mg) for an adult of 70 kg body weight. |
Paedriatic Dosage (20kg)
|
| | | | Not recommended weighing under 3 kg |
Neonatal Dosage (3kg)
|
No data regarding the neonatal dosage details of Iron Sorbitol is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Iron Sorbitol
Back to top
Previous Drug Generic - Next Drug Generic